These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 7594344

  • 1. Factors affecting quality of ulcer healing after lansoprazole treatment.
    Ito G, Nakagawara M, Watanabe F, Ooi S, Nawano M, Hanai H, Kaneko E.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S62-6. PubMed ID: 7594344
    [Abstract] [Full Text] [Related]

  • 2. Effect of lansoprazole on peptic ulcers.
    Ohashi T, Sakata J, Haraguchi Y, Eto T.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group.
    Asaki S, Sato A, Sakurada H, Takeda T, Hongo M, Toyota T.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S56-8. PubMed ID: 7594342
    [Abstract] [Full Text] [Related]

  • 4. Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori.
    Furuta T, Futami H, Arai H, Hanai H, Kaneko E.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S107-11. PubMed ID: 7594323
    [Abstract] [Full Text] [Related]

  • 5. Effects of lansoprazole on gastric ulcer healing and mucin content.
    Komuro Y, Ishii K, Miyake Y, Tanabe S, Oida M, Saigenji K.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S47-51. PubMed ID: 7594339
    [Abstract] [Full Text] [Related]

  • 6. The effect of lansoprazole treatment on the healing and relapse of peptic ulcer and serum levels of IgG anti-Helicobacter pylori antibody.
    Mine T, Yasuda H, Akimoto K, Katoaka A, Mashima H, Tajima A, Fukujin H, Tsuchida T, Takano T, Nagasawa J.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S75-8. PubMed ID: 7594347
    [Abstract] [Full Text] [Related]

  • 7. Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
    Ogoshi K, Kato T, Sakagawa T.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S97-9. PubMed ID: 7594354
    [Abstract] [Full Text] [Related]

  • 8. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter.
    Aoyama N, Kinoshita Y, Misaki F, Himeno S, Kasuga M, Chiba T.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S86-9. PubMed ID: 7594351
    [Abstract] [Full Text] [Related]

  • 10. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
    Katoh M, Asaka M, Kudoh M, Kagaya H, Katagiri M, Takeda H.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324
    [Abstract] [Full Text] [Related]

  • 11. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M, Ashida K, Umegaki E, Miyoshi H, Katsu K.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [Abstract] [Full Text] [Related]

  • 12. Quality of peptic ulcer healing induced by lansoprazole and roxatidine.
    Fujino MA, Morozumi A, Kobayashi K, Ueda F, Suzuki Y, Uchida N, Tachikawa H, Sano S, Ohtsuka H, Yamamoto Y.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S44-6. PubMed ID: 7594338
    [Abstract] [Full Text] [Related]

  • 13. Clinical study on the pathophysiology and treatment of PPI-resistant ulcers.
    Ashida K, Sakaguchi M, Tanaka M, Takiuchi H, Egashira Y, Katsu K.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S67-71. PubMed ID: 7594345
    [Abstract] [Full Text] [Related]

  • 14. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB, Faulds D, McTavish D.
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [Abstract] [Full Text] [Related]

  • 15. An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
    Brunner G, Arnold R, Hennig U, Fuchs W.
    Aliment Pharmacol Ther; 1993 Aug; 7 Suppl 1():51-5, discussion 61-6. PubMed ID: 8490080
    [Abstract] [Full Text] [Related]

  • 16. Endosonographic evaluation of the quality of ulcer healing induced by proton pump inhibitors.
    Tsukamoto Y, Goto H, Hase S, Niwa Y, Arisawa T, Hayakawa T, Yoshikane H.
    J Clin Gastroenterol; 1995 Aug; 20 Suppl 2():S40-3. PubMed ID: 7594337
    [Abstract] [Full Text] [Related]

  • 17. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h.
    Hirschowitz BI, Mohnen J, Shaw S.
    Aliment Pharmacol Ther; 1996 Aug; 10(4):497-506. PubMed ID: 8853753
    [Abstract] [Full Text] [Related]

  • 18. Lansoprazole elevates the ratio of serum pepsinogen I v.s. pepsinogen II.
    Matsukawa Y, Nishinarita S, Kaneko M, Takei M, Murakami M, Horie T, Kawamura F, Arakawa Y, Kuwayama H, Kurosaka H.
    Int J Clin Pharmacol Res; 1997 Aug; 17(4):127-32. PubMed ID: 9526173
    [Abstract] [Full Text] [Related]

  • 19. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
    Ramón Nogueira J, Esquivel Ayanegui F, Esquivel Rodríguez F, Sáenz V, Santoyo R.
    Rev Gastroenterol Mex; 1996 Aug; 61(4):314-9. PubMed ID: 9072782
    [Abstract] [Full Text] [Related]

  • 20. Proton pump inhibitors for Helicobacter pylori eradication in patients with peptic ulcer.
    Yamamoto I, Fukuda Y, Okui M, Tamura K, Shimoyama T.
    J Clin Gastroenterol; 1995 Aug; 20 Suppl 1():S38-42. PubMed ID: 7673613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.